Profile data is unavailable for this security.
About the company
Poltreg SA is a Poland-based company engaged primarily in biotechnology and medical research. The Company conducts research in the field of autoimmunological diseases. The Company works on a method of healing, that uses t-regulated cells (TREGs). The Firm possesses its own, patented technology to obtain T-regulated lymphocytes, that are used in the therapy. The Company works on therapy for diseases such as type one diabetes, type two diabetes, and multiple sclerosis. In its research, the Company cooperates with multiple specialists from various fields of science. The Company is developing its own research center, which is intended as a basic location for conducting future research activities.
- Revenue in PLN (TTM)1.50m
- Net income in PLN-9.83m
- Incorporated2016
- Employees18.00
- LocationPoltreg SAWaly Piastowskie 1 lok. 1508GDANSK 80-855PolandPOL
- Websitehttps://poltreg.tech/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Urteste SA | 0.00 | -5.62m | 139.56m | -- | -- | 4.84 | -- | -- | -4.74 | -4.74 | 0.00 | 20.47 | 0.00 | -- | -- | -- | -29.59 | -- | -30.60 | -- | -- | -- | -- | -- | 30.77 | -- | 0.0254 | -- | -- | -- | 3.38 | -- | -- | -- |
| Genomtec SA | 19.00k | -13.35m | 150.75m | -- | -- | 14.91 | -- | 7,934.05 | -1.32 | -1.32 | 0.0018 | 0.857 | 0.0014 | 24.23 | 0.0095 | -- | -95.96 | -- | -115.26 | -- | -12,973.68 | -- | -70,247.37 | -- | 4.05 | -31.75 | 0.1413 | -- | -81.72 | -- | -126.20 | -- | -- | -- |
| Sds Optic SA | 530.40k | -7.39m | 170.16m | -- | -- | 24.27 | -- | 320.81 | -1.30 | -1.30 | 0.0928 | 1.19 | 0.054 | -5.91 | 2.11 | -- | -75.38 | -- | -94.39 | -- | 167.64 | -- | -1,395.87 | -- | 4.85 | -- | 0.00 | -- | -99.59 | -- | -85.26 | -- | -- | -- |
| Poltreg SA | 1.50m | -9.83m | 241.57m | 18.00 | -- | 2.63 | -- | 161.15 | -2.11 | -2.11 | 0.3215 | 19.66 | 0.0118 | 44.40 | 15.45 | 83,277.78 | -7.74 | -- | -8.72 | -- | -736.76 | -- | -655.84 | -- | 4.72 | -- | 0.0879 | -- | -9.10 | -- | 47.38 | -- | -- | -- |
| Molecure SA | 1.31m | -18.31m | 251.87m | 111.00 | -- | 1.60 | -- | 192.47 | -1.17 | -1.17 | 0.0847 | 9.34 | 0.0085 | -- | 0.2818 | 11,788.92 | -11.94 | 2.52 | -12.47 | 2.64 | -25.76 | 97.54 | -1,398.86 | 12.84 | -- | -- | 0.0434 | -- | -18.85 | 237.24 | -19.67 | -- | -24.82 | -- |
| Mabion SA | 157.00m | 42.35m | 272.17m | 255.00 | 6.43 | 2.51 | 5.47 | 1.73 | 2.62 | 2.62 | 9.71 | 6.70 | 0.9539 | 8.23 | 28.36 | 615,701.90 | 25.73 | -24.92 | 34.58 | -79.97 | 61.40 | 46.13 | 26.97 | -73.93 | 1.88 | 4.33 | 0.0477 | -- | 188.33 | -- | 1,118.71 | -- | 18.66 | -- |
| Bioceltix SA | 0.00 | -12.73m | 286.17m | -- | -- | 20.11 | -- | -- | -3.45 | -3.45 | 0.00 | 3.45 | 0.00 | 170.52 | -- | -- | -112.58 | -- | -140.07 | -- | -- | -- | -- | -- | 5.96 | -- | 0.0071 | -- | -- | -- | -102.87 | -- | -- | -- |
| BIOTON SA | 181.64m | 2.28m | 302.24m | 358.00 | 132.88 | 0.4985 | 8.11 | 1.66 | 0.0265 | 0.0265 | 2.12 | 7.06 | 0.2228 | 0.9493 | 18.41 | 507,363.10 | 0.279 | -1.99 | 0.3437 | -2.47 | 40.11 | 45.33 | 1.25 | -8.61 | 0.2933 | 1.90 | 0.1018 | -- | -22.10 | -5.51 | 60.10 | -38.69 | 0.3284 | -- |
| Synthaverse SA | 58.61m | 4.76m | 326.95m | 239.00 | 73.98 | 3.13 | 28.71 | 5.58 | 0.0677 | 0.0677 | 0.8341 | 1.60 | 0.2732 | 1.66 | 2.76 | 245,217.60 | 2.22 | 3.53 | 2.55 | 4.32 | 60.00 | 55.62 | 8.12 | 9.59 | 0.9705 | 4.47 | 0.3834 | -- | 16.32 | 12.66 | -21.76 | -- | 111.77 | -- |
| Captor Therapeutics SA | 13.20m | -70.58m | 337.64m | 104.00 | -- | 5.37 | -- | 25.58 | -16.42 | -16.42 | 3.04 | 14.90 | 0.1256 | -- | 3.59 | 126,932.70 | -67.13 | -- | -82.96 | -- | 52.28 | -- | -534.69 | -- | -- | -- | 0.0518 | -- | 44.15 | -- | -96.65 | -- | -- | -- |
Data as of Apr 22 2024. Currency figures normalised to Poltreg SA's reporting currency: Polish New Zloty PLN
16.88%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Allianz Polska TFI SAas of 25 Nov 2022 | 366.13k | 7.85% |
| Allianz Polska PTE SAas of 12 May 2023 | 356.00k | 7.63% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 65.00k | 1.39% |
| PTE PZU SAas of 30 Jun 2023 | 0.00 | 0.00% |
| Aviva Investors Poland Towarzystwo Funduszy Inwestycyjnych SAas of 30 Dec 2022 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2021 - 31 Dec 2023Source: FactSet Research Systems Inc.
